Roberto Scorza
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
-
- Protease and Inhibitor Mechanisms 5
- Oncology 5
- Chemokine receptors and signaling 4
- Co-authors
- G Ghilardi (14 shared papers)Maria Luisa Biondi (10 shared papers)Emma Guagnellini (9 shared papers)Olivia Turri (5 shared papers)Silvana Compasso (2 shared papers)Sandra D’Alfonso (1 shared paper)P. Richiardi (1 shared paper)Flemming Pociot (1 shared paper)
In The Last Decade
Roberto Scorza
17 papers receiving 830 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 328
- Immunology and Allergy 59
- Oncology 247
- Immunology 152
- Hematology 78
Countries citing papers authored by Roberto Scorza
This map shows the geographic impact of Roberto Scorza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Scorza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Scorza more than expected).
Fields of papers citing papers by Roberto Scorza
This network shows the impact of papers produced by Roberto Scorza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Scorza. The network helps show where Roberto Scorza may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Scorza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 136 | |
| 2 | Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. | 2001 | 134 |
| 3 | A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. | 2002 | 106 |
| 4 | 2002 | 90 | |
| 5 | 2005 | 53 | |
| 6 | 2002 | 52 | |
| 7 | 2003 | 51 | |
| 8 | 2003 | 43 | |
| 9 | 1997 | 38 | |
| 10 | 2004 | 37 | |
| 11 | 2004 | 31 | |
| 12 | 2007 | 23 | |
| 13 | Ser128Arg gene polymorphism for E-selectin and severity of atherosclerotic arterial disease. | 2004 | 18 |
| 14 | 2004 | 16 | |
| 15 | 2001 | 14 | |
| 16 | Multidetector helical angio CT oblique reconstructions orthogonal to internal carotid artery for preoperative evaluation of stenosis. A prospective study of comparison with color Doppler US, digital subtraction angiography and intraoperative data. | 2003 | 13 |
| 17 | IMPIEGO CLINICO DI UNA NUOVA PENICILLINA SEMISINTETICA: L'AMOXICILLINA | 1974 | 1 |
| 18 | 1996 | 1 | |
| 19 | Diagnostica clinica ed anatomo-patologica e trattamento chirurgico delle displasie dell'arteria renale. | 1984 | 0 |
About Roberto Scorza
Roberto Scorza is a scholar working on Cancer Research, Oncology, Immunology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 19 papers that have together received 857 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Chemokine receptors and signaling (4 papers), Immunotherapy and Immune Responses (2 papers), Cell Adhesion Molecules Research (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Immune Cell Function and Interaction (2 papers), Nitric Oxide and Endothelin Effects (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Cancer Research (328 citations), Immunology and Allergy (59 citations), Oncology (247 citations), Immunology (152 citations) and Hematology (78 citations). Roberto Scorza has collaborated with scholars based in Italy and Denmark. Frequent co-authors include G Ghilardi, Maria Luisa Biondi, Emma Guagnellini, Olivia Turri, Silvana Compasso, Sandra D’Alfonso, P. Richiardi, Flemming Pociot, Maria Caputo and Anna La Torre. Their work appears in journals such as Clinical Chemistry, Stroke, Cytokine, Prostaglandins Leukotrienes and Essential Fatty Acids and Human Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.